Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Respiratory Viral Infection in Children Aged 3-12 Years

NCT06715891 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT06715891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06715891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Respiratory Viral Infection in Children Aged 3-12 Years
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Recruiting
Start date
November 11, 2024
Completion date
December 31, 2027
Enrollment
374 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory viral infection